Scynexis market cap SCYX
Share price times shares outstanding: what the whole company sells for, since 2014.
- Today, Nov 2, 2026
- $37.9M
- Highest close in our data
- $197.6M
- May 2021
Scynexis is worth $37.9M at the close on Nov 2, 2026, at $3.81 a share.
That is up 52% over the last year and down 71% over five years.
Its highest close in our data was $197.6M in May 2021.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $37.9M | $26.8M | $58.8M | +54% |
| 2025 | $24.7M | $24.6M | $53.5M | −35% |
| 2024 | $37.9M | $37.9M | $104.7M | −54% |
| 2023 | $83M | $37.6M | $135.7M | +63% |
| 2022 | $50.9M | $50.9M | $151.6M | −65% |
| 2021 | $146.1M | $81.7M | $197.6M | +75% |
| 2020 | $83.7M | $46.3M | $97.4M | +64% |
| 2019 | $50.9M | $29.5M | $91.8M | +101% |
| 2018 | $25.4M | $18.4M | $92.3M | −62% |
| 2017 | $66.3M | $41.3M | $86.8M | −13% |
| 2016 | $76.5M | $28.1M | $116.2M | −11% |
| 2015 | $86.4M | $67.2M | $130.3M | −3% |
| 2014 | $89M | $54.1M | $95.3M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Scynexis' size, closest first, today.
| Company | Market cap |
|---|---|
| SCYXScynexis | $37.9M |
| ATNMActinium Pharmaceuticals | $45M |
| SPROSpero Therapeutics | $60.6M |
| LFVNLifevantage | $73.5M |
| NATRNatures Sunshine Products | $211.5M |
| Peer median | $67M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Scynexis
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.